Abstract
Objectives
Assess the relationship between age and breast cancer-specific survival among older women and determine whether the observed age-related disparities in survival is explained by differences in breast cancer treatments received.
Methods
Women ≥65 years old at diagnosis with stage I–IIIA breast cancer diagnosed between 1997 and 1998 were recruited from four regions of the United States and followed prospectively for 5 years after diagnosis. Data was obtained from tumor registries, medical records, and telephone interviews. The primary endpoint was breast cancer-specific survival. Our independent variables were age operationalized as ≤75 years vs. >75 years, and receipt of recommended guideline therapy, adapted from the National Institutes of Health guideline consensus conference.
Results
Of 689 women, 36% were >75 years. Women >75 years were less likely to have received the following; axillary lymph node dissection (84% vs. 93%, P = 0.0003), radiotherapy (40% vs. 54%, P = 0.0003), definitive primary therapy (71% vs. 84%, P < 0.0001), chemotherapy (9% vs. 28%, P < 0.0001), and guideline therapy (31% vs. 54%, P < 0.0001). The 5-year breast cancer-specific survival was 95% (95% confidence interval [CI], 90%, 97%) for those ≤75 years who received guideline therapy, 94% (95% CI, 90%, 97%) for those ≤75 years who did not receive guideline therapy, 96% (95% CI, 88%, 99%) for those >75 years who received guideline therapy and 83% (95% CI, 74%, 89%) for those >75 years who did not receive guideline therapy, (P = 0.002) by the log-rank test.
Conclusion
Receipt of guideline therapy may reduce the age-related disparity in breast cancer survival among older women.
Similar content being viewed by others
References
NIH consensus conference (1991) Treatment of early-stage breast cancer. Jama 265(3):391–395
Eifel P, Axelson JA, Costa J, Crowley J, Curran WJ, Jr., Deshler A, Fulton S, Hendricks CB, Kemeny M, Kornblith AB, Louis TA, Markman M, Mayer R, Roter D (2001) National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1–3, 2000. J Natl Cancer Inst 93(13):979–989
NIH Consensus Development Conference statement on the treatment of earlystage breast cancer (1991) Oncology (Williston Park) 5(2):120–124
Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106–130
Surveillance, Epidermiology and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Mortality -All COD, Public-Use With State, Total U.S. (1969–2002), National Cancer Institue, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005. Underlying mortality data provided by NCHS (www.cdc.gov/nchs)
Silliman RA, Guadagnoli E, Weitberg AB, Mor V (1989) Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients. J Gerontol 44(2):M46–M50
Yancik R, Ries LG, Yates JW (1989) Breast cancer in aging women. A population based study of contrasts in stage, surgery, and survival. Cancer 63(5):976–981
Silliman RA, Troyan SL, Guadagnoli E, Kaplan SH, Greenfield S (1997) The impact of age, marital status, and physician-patient interactions on the care of older women with breast carcinoma. Cancer 80(7):1326–1334
Diab SG, Elledge RM, Clark GM (2000) Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92(7):550–556
Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffith J, Edge S, Guadagnoli E, Lynch JJ, Meropol NJ, Weeks JC, Winn R (2000) Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer 89(3):561–573
Du X, Goodwin JS (2001) Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. J Clin Oncol 19(5):1455–1461
DeMichele A, Putt M, Zhang Y, Glick JH, Norman S (2003) Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma: evidence from a tertiary care cohort of chemotherapy-eligible patients. Cancer 97(9):2150–2159
Hurria A, Leung D, Trainor K, Borgen P, Norton L, Hudis C (2003) Factors influencing treatment patterns of breast cancer patients age 75 and older. Crit Rev Oncol Hematol 46(2):121–126
Edge SB, Gold K, Berg CD, Meropol NJ, Tsangaris TN, Gray L, Petersen BM, Jr., Hwang YT, Mandelblatt JS (2002) Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma. Cancer 94(10):2534–2541
Du X, Freeman JL, Freeman DH, Syblik DA, Goodwin JS (1999) Temporal and regional variation in the use of breast-conserving surgery and radiotherapy for older women with early-stage breast cancer from 1983 to 1995. J Gerontol A Biol Sci Med Sci 54(9):M474–M478
Du X, Freeman JL, Goodwin JS (1999) The declining use of axillary dissection in patients with early stage breast cancer. Breast Cancer Res Treat 53(2):137–144
Du X, Freeman JL, Nattinger AB, Goodwin JS (2002) Survival of women after breast conserving surgery for early stage breast cancer. Breast Cancer Res Treat 72(1):23–31
Du XL, Key CR, Osborne C, Mahnken JD, Goodwin JS (2003) Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer. Ann Intern Med 138(2):90–97
Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML (2005) Breast cancer treatment guidelines in older women. J Clin Oncol 23(4):783–791
Goodwin JS, Hunt WC, Samet JM (1993) Determinants of cancer therapy in elderly patients. Cancer 72(2):594–601
Bouchardy C, Rapiti E, Fioretta G, Laissue P, Neyroud-Caspar I, Schafer P, Kurtz J, Sappino AP, Vlastos G (2003) Undertreatment strongly decreases prognosis of breast cancer in elderly women. J Clin Oncol 21(19):3580–3587
Eaker S, Dickman PW, Bergkvist L, Holmberg L (2006) Differences in Management of Older Women Influence Breast Cancer Survival: Results from a PopulationBased Database in Sweden. PLoS Med 3(3):e25
Gajdos C, Tartter PI, Bleiweiss IJ, Lopchinsky RA, Bernstein JL (2001) The consequence of undertreating breast cancer in the elderly. J Am Coll Surg 192(6):698–707
Silliman RA, Guadagnoli E, Rakowski W, Landrum MB, Lash TL, Wolf R, Fink A, Ganz PA, Gurwitz J, Borbas C, Mor V (2002) Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. J Clin Oncol 20(11):2680–2688
Greene FL, Page DL, Fleming ID, et al (eds) (2002) AJCC (American Joint Commitee on Cancer) Cancer staging manual. Springer-Verlag, New York, Pp. 223–240
Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2003) Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21(17):3357–3365
National Comprehensive Cancer Network. Clinical Practice Guidelines in Breast Cancer. Version 1.2006
Ware J (1993) SF-36 health survey: manual and interpretation guide. The Health Institute, Boston, MA
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
Wanebo HJ, Cole B, Chung M, Vezeridis M, Schepps B, Fulton J, Bland K (1997) Is surgical management compromised in elderly patients with breast cancer? Ann Surg 225(5):579–586; discussion 586–9
Greenfield S, Blanco DM, Elashoff RM, Ganz PA (1987) Patterns of care related to age of breast cancer patients. Jama 257(20):2766–2770
Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. Jama 285(7):885–892
Mandelblatt JS, Kerner JF, Hadley J, Hwang YT, Eggert L, Johnson LE, Gold K (2002) Variations in breast carcinoma treatment in older medicare beneficiaries: is it black or white. Cancer 95(7):1401–1414
Osborne C, Ostir GV, Du X, Peek MK, Goodwin JS (2005) The influence of marital status on the stage at diagnosis, treatment, and survival of older women With breast cancer. Breast Cancer Res Treat 93(1):41–47
Mandelblatt JS, Bierman AS, Gold K, Zhang Y, Ng JH, Maserejan N, Hwang YT, Meropol NJ, Hadley J, Silliman RA (2001) Constructs of burden of illness in older patients with breast cancer: a comparison of measurement methods. Health Serv Res 36(6 Pt 1):1085–1107
Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L (1999) Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85(5):1104–1113
Goodwin JS, Zhang DD, Ostir GV (2004) Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc 52(1):106–111
Acknowledgments
We thank Soe Soe Thwin of Boston University Medical Center, Department of Medicine, Section of Geriatrics, Boston, MA, for her valuable assistance in preparing data files for the project.
Supported by grants R01 CA/AG70818 from the National Cancer Institute and National Institute on Aging, R01 CA84506, K05 CA92395, CA093772-04S1 from the National Cancer Institute and an ASCO Foundation Young Investigator Award.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Owusu, C., Lash, T.L. & Silliman, R.A. Effect of undertreatment on the disparity in age-related breast cancer-specific survival among older women. Breast Cancer Res Treat 102, 227–236 (2007). https://doi.org/10.1007/s10549-006-9321-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-006-9321-x